BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19129482)

  • 1. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.
    Månsson A; Cardell LO
    J Leukoc Biol; 2009 Apr; 85(4):719-27. PubMed ID: 19129482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
    Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
    J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
    Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
    J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
    Saitoh S; Miyake K
    Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
    Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
    J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils.
    Ito W; Takeda M; Fujita M; Kamada Y; Kato H; Chiba T; Yamaguchi K; Ueki S; Kayaba H; Kanehiro A; Chihara J
    Int Arch Allergy Immunol; 2008; 147(4):331-7. PubMed ID: 18622140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
    Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
    Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor (TLR) 7 decreases and TLR9 increases the airway responses in mice with established allergic inflammation.
    Adner M; Starkhammar M; Georén SK; Dahlén SE; Cardell LO
    Eur J Pharmacol; 2013 Oct; 718(1-3):544-51. PubMed ID: 24041926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.
    Wang D; Bhagat L; Yu D; Zhu FG; Tang JX; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Jan; 52(2):551-8. PubMed ID: 19102653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages.
    Sabet M; Cottam HB; Guiney DG
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):369-79. PubMed ID: 16872373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
    Dil N; Marshall AJ
    Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation.
    Wong CK; Cheung PF; Lam CW
    Eur J Immunol; 2007 Aug; 37(8):2337-48. PubMed ID: 17634954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
    Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
    J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic agonists of Toll-like receptors 7, 8 and 9.
    Agrawal S; Kandimalla ER
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1461-7. PubMed ID: 18031246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eosinophilia and interleukin-5: role in pulmonary atopic processes].
    Druilhe A; Pretolani M
    Med Trop (Mars); 1998; 58(4 Suppl):437-43. PubMed ID: 10410362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and in ovo responses of chickens to TLR9 subfamily ligands.
    Jenkins KA; Lowenthal JW; Kimpton W; Bean AG
    Dev Comp Immunol; 2009 May; 33(5):660-7. PubMed ID: 19100284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.
    Guiducci C; Coffman RL; Barrat FJ
    J Intern Med; 2009 Jan; 265(1):43-57. PubMed ID: 19093959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.